| 0 |
URINE CHLORIDE DECREASED |
1 |
0.0417 |
| 1 |
THERMOANAESTHESIA |
1 |
0.0270 |
| 2 |
URINE SODIUM DECREASED |
1 |
0.0077 |
| 3 |
PSEUDOALDOSTERONISM |
1 |
0.0051 |
| 4 |
PHARMACEUTICAL PRODUCT COUNTERFEIT |
1 |
0.0048 |
| 5 |
MENIERE'S DISEASE |
1 |
0.0029 |
| 6 |
CIRCUMORAL OEDEMA |
1 |
0.0029 |
| 7 |
EXANTHEM |
1 |
0.0028 |
| 8 |
ENCEPHALITIS HERPES |
1 |
0.0020 |
| 9 |
CLONIC CONVULSION |
1 |
0.0014 |
| 10 |
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE |
1 |
0.0009 |
| 11 |
MUCOUS MEMBRANE DISORDER |
1 |
0.0007 |
| 12 |
MYOGLOBIN BLOOD INCREASED |
1 |
0.0007 |
| 13 |
ACCIDENTAL DRUG INTAKE BY CHILD |
1 |
0.0007 |
| 14 |
BLOOD CALCIUM ABNORMAL |
1 |
0.0006 |
| 15 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 16 |
RENAL CANCER STAGE II |
1 |
0.0006 |
| 17 |
UTERINE SPASM |
1 |
0.0005 |
| 18 |
INTENTIONAL MISUSE |
1 |
0.0005 |
| 19 |
DRUG SCREEN POSITIVE |
4 |
0.0005 |
| 20 |
FEAR OF DEATH |
1 |
0.0004 |
| 21 |
DIABETES INSIPIDUS |
1 |
0.0004 |
| 22 |
HYPERPARATHYROIDISM SECONDARY |
1 |
0.0004 |
| 23 |
MEDICATION RESIDUE |
1 |
0.0004 |
| 24 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0003 |
| 25 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 26 |
FEELING OF DESPAIR |
1 |
0.0002 |
| 27 |
ABORTION INDUCED |
2 |
0.0002 |
| 28 |
SARCOIDOSIS |
1 |
0.0002 |
| 29 |
DRUG TOLERANCE |
1 |
0.0002 |
| 30 |
CACHEXIA |
1 |
0.0002 |
| 31 |
DENTAL CARIES |
2 |
0.0002 |
| 32 |
HYPERVENTILATION |
1 |
0.0002 |
| 33 |
SINUS HEADACHE |
1 |
0.0002 |
| 34 |
DYSGRAPHIA |
1 |
0.0002 |
| 35 |
APPETITE DISORDER |
1 |
0.0002 |
| 36 |
FORMICATION |
1 |
0.0001 |
| 37 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 38 |
GINGIVAL PAIN |
1 |
0.0001 |
| 39 |
UTERINE CANCER |
1 |
0.0001 |
| 40 |
SENSORY LOSS |
1 |
0.0001 |
| 41 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 42 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 43 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 44 |
UNINTENDED PREGNANCY |
1 |
0.0001 |
| 45 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 46 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 47 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 48 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 49 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 50 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 51 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 52 |
PROTEINURIA |
1 |
0.0001 |
| 53 |
GLAUCOMA |
1 |
0.0001 |
| 54 |
NASAL CONGESTION |
3 |
0.0001 |
| 55 |
MENORRHAGIA |
1 |
0.0001 |
| 56 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 57 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 58 |
ORAL PAIN |
1 |
0.0000 |
| 59 |
TINNITUS |
2 |
0.0000 |
| 60 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 61 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 62 |
SPEECH DISORDER |
2 |
0.0000 |
| 63 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 64 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 65 |
PAIN IN JAW |
1 |
0.0000 |
| 66 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 67 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 68 |
APHASIA |
1 |
0.0000 |
| 69 |
LIP SWELLING |
1 |
0.0000 |
| 70 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 71 |
NIGHTMARE |
1 |
0.0000 |
| 72 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 73 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 74 |
PANIC ATTACK |
1 |
0.0000 |
| 75 |
RESTLESSNESS |
1 |
0.0000 |
| 76 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 77 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 78 |
DISORIENTATION |
1 |
0.0000 |
| 79 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 80 |
HYPOACUSIS |
1 |
0.0000 |
| 81 |
THROAT IRRITATION |
1 |
0.0000 |
| 82 |
SUICIDAL IDEATION |
2 |
0.0000 |
| 83 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 84 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 85 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 86 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 87 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 88 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 89 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 90 |
DYSPHONIA |
1 |
0.0000 |
| 91 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 92 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 93 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 94 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 95 |
SWELLING FACE |
1 |
0.0000 |
| 96 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 97 |
RENAL FAILURE |
2 |
0.0000 |
| 98 |
HYPOAESTHESIA |
2 |
0.0000 |
| 99 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 100 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 101 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 102 |
BALANCE DISORDER |
1 |
0.0000 |
| 103 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 104 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 105 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 106 |
SWELLING |
1 |
0.0000 |
| 107 |
ANXIETY |
3 |
0.0000 |
| 108 |
DYSPHAGIA |
1 |
0.0000 |
| 109 |
SYNCOPE |
1 |
0.0000 |
| 110 |
SINUSITIS |
1 |
0.0000 |
| 111 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 112 |
HAEMORRHAGE |
1 |
0.0000 |
| 113 |
MALAISE |
4 |
0.0000 |
| 114 |
ASTHMA |
1 |
0.0000 |
| 115 |
PYREXIA |
3 |
0.0000 |
| 116 |
DECREASED APPETITE |
2 |
0.0000 |
| 117 |
PALPITATIONS |
1 |
0.0000 |
| 118 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 119 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 120 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 121 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 122 |
INFECTION |
1 |
0.0000 |
| 123 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 124 |
DRUG INTERACTION |
1 |
0.0000 |
| 125 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 126 |
COVID-19 |
1 |
0.0000 |
| 127 |
MUSCLE SPASMS |
1 |
0.0000 |
| 128 |
CHEST PAIN |
1 |
0.0000 |
| 129 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 130 |
ANAEMIA |
1 |
0.0000 |
| 131 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 132 |
WEIGHT INCREASED |
1 |
0.0000 |
| 133 |
VOMITING |
2 |
0.0000 |
| 134 |
FEELING ABNORMAL |
1 |
0.0000 |
| 135 |
DIZZINESS |
2 |
0.0000 |
| 136 |
FATIGUE |
3 |
0.0000 |
| 137 |
NAUSEA |
3 |
0.0000 |
| 138 |
INSOMNIA |
1 |
0.0000 |
| 139 |
DYSPNOEA |
2 |
0.0000 |
| 140 |
HEADACHE |
2 |
0.0000 |
| 141 |
PNEUMONIA |
1 |
0.0000 |
| 142 |
FALL |
1 |
0.0000 |
| 143 |
PRURITUS |
1 |
0.0000 |
| 144 |
RASH |
1 |
0.0000 |
| 145 |
DRUG INEFFECTIVE |
3 |
0.0000 |